Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms
Recruiting · NCT07448558 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
tailored exercise
What this trial is about
A randomized controlled study evaluating effect of tailored exercise compared to routine practice as a preventive measure of aromatase inhibitor associated musculoskeletal related symptoms in early breast cancer patients
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- breast cancer patients with starting adjuvant aromatase inhibitor within 4 weeks
- able to read and write
Exclusion criteria
- chronic arthritis
- history of heart failure or acute coronary syndrome within 6 months
- individuals who exercises regularly more than 150 minutes/week
Where it is running
1 location listed.
- Faculty of Medicine Siriraj Hospital, Mahidol University - Bangkok, Thailand